A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck
Danielle N. Margalit, Robert I. Haddad, R. B. Tishler, Nicole G. Chau, Jonathan D. Schoenfeld, Richard L. Bakst, Krzysztof J. Misiukiewicz, Vishal Gupta, Marshall Posner, Glenn J. Hanna, U. Mahmood, Bhupendra Rawal, Paul J. Catalano, L. Rath, Alyssa Bacay, Patricia McHugh, Guilherme Rabinowits
Research output: Contribution to journal › Article › peer-review
10Scopus
citations
Fingerprint
Dive into the research topics of 'A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck'. Together they form a unique fingerprint.